LATEST UPDATES & INDUSTRY NEWS

If you’re over your JP Morgan hangover, share your pitch deck on our website and we’ll see what we can do.

Promises, Promises. Lot’s of pressure on NYE. Our resolution is to do more of what we’ve been doing. Giving the best service possible to small and emerging drug, medical device and diagnostic companies. So “our” promise is to keep on, keeping on.

Andrew started off with Proxima as a Business Development Intern and immediately took leadership of other roles. Although he was helping in all aspects of the company, he showed an extreme interest in Regulatory.

Intelligent Implants has been a rising star in the medical device community, winning the Johnson and Johnson CDI Start-Up competition, receiving $250,000 from the TMC Venture Fund, being honored as the Most Promising Life Science Company...

Catch Proxima's regulatory affairs consultant, Isabella Schmitt, on Greenlight Guru's podcast on "Preparing for EU MDR" this week.

The FDA’s new draft guidance on clinical decision support software (CDS) is a major revision of a prior draft guidance issued on December 8, 2017. It explains the FDA’s method of interpreting section 520(o) of the Federal Food, Drug, and Cosmetic Act

Come visit our booth at the Texas Life Science Forum and checkout our Fireside Chat, Negotiating with the FDA, with Bob Whitehead, CoFounder and Director Sprout Pharmaceuticals.

In December 2018, FDA announced plans for a new program--the Safer Technologies Program, also known as STeP, and on September 18, 2019, draft guidance for the STeP program was released.

At Proxima Clinical Research, our clinical project managers are here to help you foresee the potential risks in your study as well as help you fix or avoid them altogether.